Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» BMS-936558
BMS-936558
Tackling Cancer: Kidney Cancer's Biggest Current and Upcoming Players
Motley Fool
Mon, 05/6/13 - 09:12 am
kidney cancer
ONYX Pharmaceuticals
Bayer
Nexavar
Roche
Avastin
Inlyta
Sutent
Pfizer
Votrient
GSK
Afinitor
Novartis
BMS-936558
Bristol-Myers Squibb
tivozanib
Aveo Oncology
Bristol-Myers Has The Future Of Oncology Therapies
Seeking Alpha
Sun, 05/5/13 - 11:00 am
Bristol-Myers Squibb
nivolumab
BMS-936558
non-small cell lung cancer
renal cell carcinoma
melanoma
Ono Pharmaceutical
tivozanib
Aveo Pharmaceuticals
elotuzumab
Important Cancer Therapeutics Under Development To Watch
Seeking Alpha
Tue, 06/5/12 - 09:34 am
cabozantinib
Exelixis
BMS-936558
MDX-1106
cancer
anti-PD-1 immunotherapy
Bristol-Myers Squibb
Bristol-Myers Immune Drug Puts Deadly Cancers on Hold in Study
Bloomberg
Sun, 06/3/12 - 11:18 am
skin cancer
Bristol-Myers Squibb
BMS-936558
kidney cancer
lung cancer
Bristol Drug Seen Helping Body Attack Lung Cancer: Health
Bloomberg
Wed, 05/30/12 - 10:21 am
Bristol-Myers Squibb
BMS-936558
lung cancer
Bristol-Myers Squibb Zeroes In On A Blockbuster Cancer Drug
Seeking Alpha
Tue, 09/27/11 - 07:31 pm
Bristol-Myers Squibb
Orencia
MDX-1106
BMS-936558
Ono Pharmaceutical